Genetic Polymorphisms as Key Modulators of Cardiovascular Risk from Endocrine-Disrupting Chemicals
Genes · 21.06.2026 · 17 (6) · 717
DOI: 10.3390/genes17060717 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 21.06.2026. Verfasst von Mariangela Palazzo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Endocrine Disruptors, Gene-Environment Interaction, Oxidative Stress. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Environmental exposure to persistent and non-persistent endocrine-disrupting chemicals (EDCs), including per- and polyfluoroalkyl substances (PFAS), polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), polycyclic aromatic hydrocarbons (PAHs), dioxins, phthalates, and bisphenols, has been increasingly associated with elevated cardiovascular disease (CVD) risk. Emerging evidence suggests the importance of gene–environment interactions in modulating individual susceptibility to EDC-related cardiovascular effects. This review summarizes current knowledge by synthesizing the main classes of EDCs, evaluating the evidence linking them to cardiovascular outcomes, and highlighting how genetic variability may modulate EDC-induced cardiovascular risk. Across the studies analyzed, the most extensively investigated genetic polymorphisms involve pathways related to oxidative stress regulation, xenobiotic metabolism and detoxification, hormone signaling, and lipid homeostasis. Variants in antioxidant defense genes, such as CAT, eNOS, and PON1, have been associated with increased hypertension risk and vascular dysfunction following exposure to bisphenols and PAHs. Polymorphisms in GSTP1, CYP2C19, CYP1A2, CYP2E1, ABCB1, and MTHFR may influence susceptibility to cardiometabolic alterations and congenital heart defects, whereas variants in ESR2, FTO, LEPR, and INSIG2 have been linked to obesity, dyslipidemia, and hypertension associated with PFAS, PBDEs, and bisphenols. A deeper understanding of gene–environment interactions is essential to advance preventive cardiology and mitigate the cardiovascular impact of environmental pollutants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.
ORCID-Profile: Francesca Gorini, Ludovica Simonini, Fabrizio Minichilli, Andrea Borghini
Zitieren
APA
Palazzo, M., Gorini, F., Simonini, L., Minichilli, F., & Borghini, A. (2026). Genetic Polymorphisms as Key Modulators of Cardiovascular Risk from Endocrine-Disrupting Chemicals. Genes, 17(6), 717. https://doi.org/10.3390/genes17060717
Vancouver
Palazzo M, Gorini F, Simonini L, Minichilli F, Borghini A. Genetic Polymorphisms as Key Modulators of Cardiovascular Risk from Endocrine-Disrupting Chemicals. Genes. 2026;17(6):717. doi:10.3390/genes17060717
BibTeX
@article{Palazzo2026,
author = {Palazzo, Mariangela and Gorini, Francesca and Simonini, Ludovica and Minichilli, Fabrizio and Borghini, Andrea},
title = {Genetic Polymorphisms as Key Modulators of Cardiovascular Risk from Endocrine-Disrupting Chemicals},
journal = {Genes},
year = {2026},
volume = {17},
number = {6},
pages = {717},
doi = {10.3390/genes17060717}
}
EUVIMED